Sugi Predict

Sugi Predict / Compounds / Trimethylammonium

Trimethylammonium

Trimethylammonium

SCHEMBL1263576

CCCCCCCCBr.CN(C)C

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.50
▸ THRB P10828 1/20 0.50
▸ DNM1 Q05193 8/20 0.48
▸ ALDH1A1 P00352 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SLC22A1 O15245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL1150051 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Trimethylammonium SCHEMBL1274146 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Trimethylammonium SCHEMBL876163 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Trimethylammonium SCHEMBL11673563 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Trimethylammonium SCHEMBL16738271 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Trimethylammonium SCHEMBL320626 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Trimethylammonium SCHEMBL25438207 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Trimethylammonium SCHEMBL2181606 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Trimethylammonium SCHEMBL28043 1.00 TSHR (0.50) TSHRTHRBDNM1ALDH1A1LMNA
Trimethylammonium SCHEMBL196460 0.97 TSHR (0.47) TSHRTHRBDNM1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118225654-A Blood cell counting kit and classification counting method 基蛋生物科技股份有限公司 2024-06-21 — — CN claimed
CN-118084054-A Quaternary ammonium salt intercalated bismuth sulfide microsphere for sodium ion battery and preparation method and application thereof 郑州工程技术学院 2024-05-28 — — CN claimed
CN-108135967-B Composition with penetration enhancer for drug delivery 儿童医学中心公司 2022-06-28 — — CN claimed
CN-111372903-A Temporary bonding of glass pairs using cationic surfactants and/or organic salts 康宁股份有限公司 2020-07-03 — — CN claimed
CN-103992426-B A kind of antibacterial high water-absorbent resin and preparation method thereof 浙江卫星石化股份有限公司 2017-03-29 — — CN claimed
US-9385367-B2 Approach for manufacturing efficient mesoporous nano-composite positive electrode LiMn1-xFexPO4 materials NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-07-05 — — US claimed
US-9327990-B2 Production of nanostructured Li4Ti5O12 with superior high rate performance NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-05-03 — — US claimed
CN-103992426-A Bacterium resisting type high water absorption resin and preparation method thereof ZHEJIANG SATELLITE PETRO CHEMICAL CO LTD 2014-08-20 — — CN claimed
US-20140220448-A1 PRODUCTION OF NANOSTRUCTURED LI4TI5O12 WITH SUPERIOR HIGH RATE PERFORMANCE NATIONAL UNIVERSITY OF SINGAPORE (SG) 2014-08-07 — — US claimed
US-20140134490-A1 APPROACH FOR MANUFACTURING EFFICIENT MESOPOROUS NANO-COMPOSITE POSITIVE ELECTRODE LiMn1-xFexPO4 MATERIALS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2014-05-15 — — US claimed
US-20140113196-A1 SYNTHESIS OF MESOPOROUS TRANSITION METAL OXIDES AS ANODE MATERIALS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2014-04-24 — — US claimed
WO-2013002730-A1 AN APPROACH FOR MANUFACTURING EFFICIENT MESOPOROUS NANO-COMPOSITE POSITIVE ELECTRODE LIMN1-XFEXPO4 MATERIALS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-01-03 — — WO claimed
WO-2013002728-A1 SYNTHESIS OF MESOPOROUS TRANSITION METAL OXIDES AS ANODE MATERIALS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-01-03 — — WO claimed
US-20080305157-A1 Encapsulation and separation of charged organic solutes inside catanionic vesicles UNIVERSITY OF MARYLAND OFFICE OF TECHNOLOGY COMMERCIALIZATION (US) 2008-12-11 — — US claimed
EP-4721819-A2 STABLE BACTERIAL EXTRACTS AS PHARMACEUTICALS OM Pharma SA (CH) 2026-04-08 — — EP disclosed
US-20250302751-A1 FORMULATIONS FOR ADMINISTERING LAAM, norLAAM AND dinorLAAM AND METHODS OF THEIR USE TO TREAT OPIOID USE DISORDER UNIV VIRGINIA COMMONWEALTH (US) 2025-10-02 — — US disclosed
US-20250195587-A1 STABLE BACTERIAL EXTRACTS AS PHARMACEUTICALS OM PHARMA SA (CH) 2025-06-19 — — US disclosed
US-5278256-A Depolymerization E. I. DU PONT DE NEMOURS AND COMPANY (US) 1994-01-11 — — US disclosed
US-5165994-A Spontaneous equilbrium surfactant vesicles UNIVERSITY OF DELAWARE (US) 1992-11-24 — — US disclosed
US-4135929-A REDOX RELEASING, PHOTOGRAPHIC FILMS EASTMAN KODAK COMPANY (US) 1979-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250302751-A1 FORMULATIONS FOR ADMINISTERING LAAM, norLAAM AND dinorLAAM AND METHODS OF THEIR USE TO TREAT OPIOID USE DISORDER OPRM1, OPRK1, OPRD1 TSHR 4154/4885THRB 2866/4885DNM1 2513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.